Clinical Trials Insight: 700027120
Latest Information Update: 24 Sep 2007
At a glance
- Drugs Verpasep caltespen (Primary)
- Indications Cervical cancer; Cervical intraepithelial neoplasia; Human papillomavirus infections
- Focus Therapeutic Use
- Sponsors Nventa Biopharmaceuticals Corporation
- 24 Sep 2007 New trial record.